ARTIDIS® is our nanomechanical sensor that captures the physical properties of tumor cells and their microenvironment, the stroma, with very high accuracy allowing us to develop robust nanomechanical signatures and predict treatment response enabling clinicians to:
1) Differentiate between benign and malignant tissue in under three hours, and
2) Define the imminent aggressiveness of tumors, measured by:
· The presence of soft cells which can deform and squeeze through the blood or lymph system and form new tumors in other parts of the body
· The heterogeneity of the tumor tissue, which is in turn linked to permeability to cancer treatment
ARTIDIS technology is not limited to cancer and can analyze any living tissue with applications in ophthalmology, orthopedics (cartilage, bone), dermatology (skin) and biomedical engineering.